{"database": "lobbying", "table": "lobbying_activities", "rows": [[3488251, "16ca5dd8-0fdb-4621-a443-49eedd19fc02", "Q4", "MARSHALL & POPP, LLC", 401105121, "CSL BEHRING", 2025, "fourth_quarter", "PHA", "Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to regulation of pharmaceuticals. H.R.1476-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act).", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2026-01-16T10:42:23-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3488251"], "units": {}, "query_ms": 9.305696992669255, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}